Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vitro and Animal Models for Emerging Diseases and Biodefense
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The new chemokine CCL28 and its role during Salmonella infection
Socioeconomic gradients in mortality new questions about personality and IQ
Mechanism of Class III viral fusion proteins.
Phase I Safety and Immunogenicity Trial of Canarypox GP160 MN
Biochemical Genetics of Childhood Immunodeficiency
Recently added grants:
Signaling pathways that regulate scaling and regeneration of the cerebellum
The Circadian Molecular Clock is a Biomarker for Epilepsy in Focal Cortical Dysplasia
Interneuron-based mechanisms of temporal lobe epilepsy
Novel combinatory therapy for experimental ischemic stroke
Impact of excitatory synapse maturation on synaptic plasticity and stability
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI30065-9-0-1
Application #
7580027
Study Section
Project Start
2003-09-30
Project End
2010-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 AI
In Vitro and Animal Models for Emerging Diseases and Biodefense
/ University of Texas Medical Br Galveston
$2,025,158
NIH 2008
N01 AI
In Vitro and Animal Models for Emerging infectious Diseases and Biodefense
/ University of Texas Medical Br Galveston
$1,366,579
NIH 2008
N01 AI
In Vitro and Animal Models for Emerging Infectious Diseases and Biodefense
/ University of Texas Medical Br Galveston
$1,309,766
NIH 2007
N01 AI
In Vitro and Animal Models for Emerging Diseases and Biodefense (IDIQ)
Stanberry, Lawernce /
$502,000
NIH 2007
N01 AI
In Vitro and Animal Models for Emerging Diseases and Biodefense
/
Comments
Be the first to comment on this grant